This unexpected ability opens the door for scientists to stimulate cellular mitosis and improve heart function after an ...

DENVER--(BUSINESS WIRE)--Cleerly, the company working to create a new standard of care for the diagnosis of heart disease, today announced the launch of Cleerly ISCHEMIA, which recently received U.S.

AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...

This winter, as you go about bundling up daily to keep yourself warm, offers a timely opportunity to check on your heart health. Cold temperatures require your body to work harder to stay warm, and ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Please provide your email address to receive an email when new articles are posted on . “Remarkably, we found that all of them were independent long-term risk factors for ischemic heart disease, even ...

Allopurinol, a drug commonly used to treat gout, provided no benefit in terms of reducing cardiovascular (CV) events in patients with ischemic heart disease, new randomized trial results show.

NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced a key publication in the ...

The "rapid recovery with extended ultraoxygenated preservation" (REUP) technique, which does not require pre-implant donor ...